102 related articles for article (PubMed ID: 22505523)
1. Kallikrein-related peptidase signaling in colon carcinoma cells: targeting proteinase-activated receptors.
Chung H; Hamza M; Oikonomopoulou K; Gratio V; Saifeddine M; Virca GD; Diamandis EP; Hollenberg MD; Darmoul D
Biol Chem; 2012 Apr; 393(5):413-20. PubMed ID: 22505523
[TBL] [Abstract][Full Text] [Related]
2. Kallikrein-related peptidase 14 acts on proteinase-activated receptor 2 to induce signaling pathway in colon cancer cells.
Gratio V; Loriot C; Virca GD; Oikonomopoulou K; Walker F; Diamandis EP; Hollenberg MD; Darmoul D
Am J Pathol; 2011 Nov; 179(5):2625-36. PubMed ID: 21907696
[TBL] [Abstract][Full Text] [Related]
3. Kallikrein-related peptidase 7 (KLK7) is a proliferative factor that is aberrantly expressed in human colon cancer.
Walker F; Nicole P; Jallane A; Soosaipillai A; Mosbach V; Oikonomopoulou K; Diamandis EP; Magdolen V; Darmoul D
Biol Chem; 2014 Sep; 395(9):1075-86. PubMed ID: 25153388
[TBL] [Abstract][Full Text] [Related]
4. Proteinase-activated receptors (PARs): differential signalling by kallikrein-related peptidases KLK8 and KLK14.
Ramachandran R; Eissa A; Mihara K; Oikonomopoulou K; Saifeddine M; Renaux B; Diamandis E; Hollenberg MD
Biol Chem; 2012 Apr; 393(5):421-7. PubMed ID: 22505524
[TBL] [Abstract][Full Text] [Related]
5. Parallel overexpression and clinical significance of kallikrein-related peptidases 7 and 14 (KLK7KLK14) in colon cancer.
Devetzi M; Trangas T; Scorilas A; Xynopoulos D; Talieri M
Thromb Haemost; 2013 Apr; 109(4):716-25. PubMed ID: 23224034
[TBL] [Abstract][Full Text] [Related]
6. Kallikrein-related peptidase 4: a new activator of the aberrantly expressed protease-activated receptor 1 in colon cancer cells.
Gratio V; Beaufort N; Seiz L; Maier J; Virca GD; Debela M; Grebenchtchikov N; Magdolen V; Darmoul D
Am J Pathol; 2010 Mar; 176(3):1452-61. PubMed ID: 20056842
[TBL] [Abstract][Full Text] [Related]
7. Effects of kallikrein-related peptidase 14 gene inhibition by small interfering RNA in ovarian carcinoma cells.
Zhang R; Shi H; Chen Z; Feng W; Zhang H; Wu K
Mol Med Rep; 2012 Jan; 5(1):256-9. PubMed ID: 21993700
[TBL] [Abstract][Full Text] [Related]
8. Prostate-specific kallikreins-2 and -4 enhance the proliferation of DU-145 prostate cancer cells through protease-activated receptors-1 and -2.
Mize GJ; Wang W; Takayama TK
Mol Cancer Res; 2008 Jun; 6(6):1043-51. PubMed ID: 18567807
[TBL] [Abstract][Full Text] [Related]
9. Quantitative RT-PCR analysis and immunohistochemical localization of the kallikrein-related peptidases 13 and 14 in lung.
Planque C; Bléchet C; Ayadi-Kaddour A; Heuzé-Vourc'h N; Dumont P; Guyétant S; Diamandis EP; El Mezni F; Courty Y
Biol Chem; 2008 Jun; 389(6):781-6. PubMed ID: 18627302
[TBL] [Abstract][Full Text] [Related]
10. Kallikrein-related peptidase 4 (KLK4) initiates intracellular signaling via protease-activated receptors (PARs). KLK4 and PAR-2 are co-expressed during prostate cancer progression.
Ramsay AJ; Dong Y; Hunt ML; Linn M; Samaratunga H; Clements JA; Hooper JD
J Biol Chem; 2008 May; 283(18):12293-304. PubMed ID: 18308730
[TBL] [Abstract][Full Text] [Related]
11. The molecular function of kallikrein-related peptidase 14 demonstrates a key modulatory role in advanced prostate cancer.
Kryza T; Bock N; Lovell S; Rockstroh A; Lehman ML; Lesner A; Panchadsaram J; Silva LM; Srinivasan S; Snell CE; Williams ED; Fazli L; Gleave M; Batra J; Nelson C; Tate EW; Harris J; Hooper JD; Clements JA
Mol Oncol; 2020 Jan; 14(1):105-128. PubMed ID: 31630475
[TBL] [Abstract][Full Text] [Related]
12. Initiation of human colon cancer cell proliferation by trypsin acting at protease-activated receptor-2.
Darmoul D; Marie JC; Devaud H; Gratio V; Laburthe M
Br J Cancer; 2001 Sep; 85(5):772-9. PubMed ID: 11531266
[TBL] [Abstract][Full Text] [Related]
13. Heregulin-induced VEGF expression via the ErbB3 signaling pathway in colon cancer.
Yonezawa M; Wada K; Tatsuguchi A; Akamatsu T; Gudis K; Seo T; Mitsui K; Nagata K; Tanaka S; Fujimori S; Sakamoto C
Digestion; 2009; 80(4):215-25. PubMed ID: 19797898
[TBL] [Abstract][Full Text] [Related]
14. PAR-2 activation increases human intestinal mucin secretion through EGFR transactivation.
Jarry A; Dorso L; Gratio V; Forgue-Lafitte ME; Laburthe M; Laboisse CL; Darmoul D
Biochem Biophys Res Commun; 2007 Dec; 364(3):689-94. PubMed ID: 18028876
[TBL] [Abstract][Full Text] [Related]
15. 15-deoxy-Delta12,14 prostaglandin J2 up-regulates Kruppel-like factor 4 expression independently of peroxisome proliferator-activated receptor gamma by activating the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signal transduction pathway in HT-29 colon cancer cells.
Chen ZY; Tseng CC
Mol Pharmacol; 2005 Nov; 68(5):1203-13. PubMed ID: 16077033
[TBL] [Abstract][Full Text] [Related]
16. Activation of PAR2 or/and TLR4 promotes SW620 cell proliferation and migration via phosphorylation of ERK1/2.
Zhou B; Zhou H; Ling S; Guo D; Yan Y; Zhou F; Wu Y
Oncol Rep; 2011 Feb; 25(2):503-11. PubMed ID: 21152870
[TBL] [Abstract][Full Text] [Related]
17. Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells.
Gilad LA; Bresler T; Gnainsky J; Smirnoff P; Schwartz B
J Endocrinol; 2005 Jun; 185(3):577-92. PubMed ID: 15930183
[TBL] [Abstract][Full Text] [Related]
18. Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer.
Campbell-Thompson M; Lynch IJ; Bhardwaj B
Cancer Res; 2001 Jan; 61(2):632-40. PubMed ID: 11212261
[TBL] [Abstract][Full Text] [Related]
19. Kallikreins and proteinase-mediated signaling: proteinase-activated receptors (PARs) and the pathophysiology of inflammatory diseases and cancer.
Hollenberg MD; Oikonomopoulou K; Hansen KK; Saifeddine M; Ramachandran R; Diamandis EP
Biol Chem; 2008 Jun; 389(6):643-51. PubMed ID: 18627296
[TBL] [Abstract][Full Text] [Related]
20. Trypsin stimulates the phosphorylation of p42,44 mitogen-activated protein kinases via the proteinase-activated receptor-2 and protein kinase C epsilon in human cultured prostate stromal cells.
Myatt A; Hill SJ
Prostate; 2005 Jul; 64(2):175-85. PubMed ID: 15678497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
